OOIR: Observatory of International Research

Papers

(The H4-Index of Annals of Neurology is 55. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis	344
COVID‐19: A Global Threat to the Nervous System	344
Steroid‐Responsive Encephalitis in Coronavirus Disease 2019	188
Guillain‐Barré Syndrome following ChAdOx1‐S/nCoV‐19 Vaccine	144
ANA Investigates: Neurological Complications of COVID‐19 Vaccines	140
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial	132
Guillain–Barré Syndrome Variant Occurring after SARS‐CoV‐2 Vaccination	128
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum	127
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)	126
Role of B Cells in Multiple Sclerosis and Related Disorders	120
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease	114
COVID‐19 Vaccine Response in People with Multiple Sclerosis	108
Gut Microbiome in Progressive Multiple Sclerosis	108
COVID‐19 Vaccine‐Associated Cerebral Venous Thrombosis in Germany	99
Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi‐Omics	98
The Impact of SARS‐CoV‐2 on Stroke Epidemiology and Care: A Meta‐Analysis	95
Radiologically Isolated Syndrome: 10‐Year Risk Estimate of a Clinical Event	91
Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study	86
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients	83
Postvaccinal Encephalitis after ChAdOx1 nCov‐19	82
Aerobic Exercise Alters Brain Function and Structure in Parkinson's Disease: A Randomized Controlled Trial	81
Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome	78
Ultra‐Early Blood Pressure Reduction Attenuates Hematoma Growth and Improves Outcome in Intracerebral Hemorrhage	78
Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies	77
Longitudinal Assessment of Multiple Sclerosis with the Brain‐Age Paradigm	75

Neurological Events Reported after COVID‐19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System	75
Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study	75
Incidence, clinical, risk factors and outcomes of Guillain‐Barré in Covid‐19	75
Left Prefrontal Connectivity Links Subthalamic Stimulation with Depressive Symptoms	74
Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease	72
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker	71
Pediatric Ischemic Stroke: An Infrequent Complication of SARS‐CoV‐2	70
Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease	70
Neurosurgical Intervention for Supratentorial Intracerebral Hemorrhage	69
Preservation of Brain Activity in Unresponsive Patients Identifies MCS Star	69
Temporal Lobe Epilepsy Surgical Outcomes Can Be Inferred Based on Structural Connectome Hubs: A Machine Learning Study	68
Loss‐of‐Function Variants in HOPS Complex Genes VPS16 and VPS41 Cause Early Onset Dystonia Associated with Lysosomal Abnormalities	66
Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019	66
Probabilistic Mapping of Deep Brain Stimulation: Insights from 15 Years of Therapy	65
Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis	65
Multisystem Involvement in Post‐Acute Sequelae of Coronavirus Disease 19	65
Identifying Progression in Multiple Sclerosis: New Perspectives	65
Inflammatory Cytokine Patterns Associated with Neurological Diseases in Coronavirus Disease 2019	62
Real‐World Effectiveness of Initial Disease‐Modifying Therapies in Pediatric Multiple Sclerosis	62
Anti‐migraine Calcitonin Gene–Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice	61
Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline	61
SARS‐CoV‐2 and Mitochondrial Proteins in Neural‐Derived Exosomes of COVID‐19	60
Extra‐Axial Inflammatory Signal in Parameninges in Migraine with Visual Aura	59
Effects of IgLON5 Antibodies on Neuronal Cytoskeleton: A Link between Autoimmunity and Neurodegeneration	58
Association of Plasma Neurofilament Light with Postoperative Delirium	58
An Overview of Monkeypox Virus and Its Neuroinvasive Potential	57
Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy	56
Blood–Brain Barrier Breakdown in Relationship to Alzheimer and Vascular Disease	56
Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function	56
Amylin Analog Pramlintide Induces Migraine‐like Attacks in Patients	56
A Prospective Study of Acute Blood‐Based Biomarkers for Sport‐Related Concussion	55